A Themed Issue in Honor of Professor Aditya Gupta—Outstanding Contributions to Antifungal Therapy, Dermatology and Mycology
A special issue of Antibiotics (ISSN 2079-6382).
Deadline for manuscript submissions: 31 January 2026 | Viewed by 17
Special Issue Editors
Interests: skin mycology yeasts; onychomycosis; aspergillosis; hidradenitis suppurativa
Special Issue Information
Dear Colleagues,
Dr. Aditya K. Gupta is a distinguished dermatologist and hair transplant surgeon whose career spans clinical dermatology, onychomycosis, and hair disorders. With over 900 peer-reviewed publications and book chapters, and an h-index of 121, his scholarly contributions have advanced dermatologic science and clinical practice worldwide.
Dr. Gupta obtained his medical degree from the University of Southampton Medical School in the United Kingdom and later earned a PhD in Dermatology from the University of Göteborg and Sahlgrenska University Hospital, Sweden. His academic trajectory is further distinguished by MBAs in both general management and healthcare management, reflecting his commitment to integrated, evidence-based innovation in clinical research.
Currently, Dr. Gupta is a Professor in the Division of Dermatology, Department of Medicine at the University of Toronto and serves as a Director of Clinical Research and Laboratory Director at Mediprobe Research Inc., a leading site for Phase II–IV dermatological trials in London, Ontario. His leadership at Mediprobe is underscored by over two decades of pioneering work in clinical mycology, antifungal resistance, and the treatment of dermatophytosis.
A certified investigator (CPI, CCRP), Dr. Gupta is extensively involved in regulatory-compliant trials and has been instrumental in developing modern paradigms for the diagnosis and treatment of onychomycosis. His expertise spans multiple domains: from the application of polymerase chain reaction (PCR) diagnostics to network meta-analyses that guide therapeutic decisions in alopecia and vitiligo.
Dr. Gupta's editorial and advisory roles are equally robust. He serves on the editorial boards of numerous journals including Journal of the American of Dermatology (JAAD Reviews), Journal of Dermatological Treatment, Journal of Drugs in Dermatology (Senior Associate Editor), Journal of Cosmetic Dermatology (Associate Editor), and SKINMed (Deputy Editor). His contributions are valued by The New England Journal of Medicine, Lancet, and Journal of Investigative Dermatology, among others, where he has served as peer reviewer.
Throughout his career, Dr. Gupta has received multiple awards, including the ISHRS Platinum Follicle Award (2023), numerous poster and innovation awards, and competitive research grants supporting investigations into androgenetic alopecia, low-dose oral minoxidil safety, and musculoskeletal health among hair transplant surgeons. His sustained excellence and leadership have shaped best practices and set new standards in dermatological therapeutics and cosmetic science.
Antibiotics is pleased to announce a Special Issue honoring Dr. Aditya K. Gupta for his outstanding and sustained contributions to the diagnosis, treatment, and global epidemiology of onychomycosis and superficial fungal infections. This Special Issue is dedicated to all aspects of onychomycosis and superficial fungal infections, including antifungal resistance, molecular diagnostics, treatment algorithms, clinical trial innovations, and stewardship strategies to optimize therapeutic outcomes in an era of emerging resistance.
Prof. Dr. Ditte Marie Saunte
Prof. Dr. Mesbah Talukder
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- onychomycosis
- antifungal resistance
- dermatophyte infections
- antifungal stewardship
- Trichophyton indotineae
- topical and oral antifungals
- treatment algorithms
- epidemiology of onychomycosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
